Skip Navigation

2012.07.30 Weekly Broadcast Email

The following updates were made to the CCCWFU CCOP Research Base website for the week of July 30, 2012.

 Registration Open for Annual Meeting

The CCCWFU CCOP Research Base 12th Annual Meeting will be held October 25-27, 2012 in Alexandria, VA.  Online registration is now available on ourwebsite. Workshops on Minority Recruitment and Retention as well as a Quitline Certification Refresher will be offered. Talks on Taste/Smell Abnormalities in Patients with Cancer, Use of Biomarkers in Clinical Trials and Human Personalities in the Workplace will be presented during general sessions and the physician tract will offer an afternoon of sessions geared towards the community based practice.Contact Lisa Autry with any questions.

We look forward to seeing you at the Hilton Alexandria Oldtown.

Accrual Totals:
The CCCWFU CCOP Research Base sites accrued 47 patients during the month of July. Congratulations to CTSU and San Juan CCOP for accruing the most patients.   See the Research Base website spotlight section for further information.

Adverse Events:

There was one adverse events received during the month of July.

99211 AE 1 has been attached to this email and summarized on the AE page of the website.


98110:(A Randomized Phase II Dose Finding Study of ArginMax with or without Phosphodiesterase-5 Inhibitors for Its Effect on Erectile Function and Quality of Life in Survivors of Prostate Cancer Previously Treated with Radiotherapy)

The WFU 2012 Continuing Review documents have been added to thewebsite.


97509:(A Feasibility Study of Armodafinil for Brain Radiation-Induced Fatigue):

The Armodafinil study only has 2 accrual slots still remaining. We would like to close this study to accrual by the end of August. Please keep this study in mind as you screen patients.

 97609:(Impact of Genomics and Exposures on Disparities in Breast Cancer Radiosensitivity)

There have been some questions regarding the “End of Radiation Therapy” sample draw. One of the primary endpoints of this study is to establish whether a change occurs in the genetic biomarkers found within the samples of patients receiving radiation therapy. Therefore the “End of Radiation Therapy” sample draw is crucial to the study. Understanding that samples cannot be shipped to the Wake Forest Lab on Fridays, these samples must be collected and sent to the lab for analysis as soon as possible following the last day of radiation therapy.




Quick Reference

Research Base

Phone 336-716-0891
Fax 336-716-6275


Medical Center Boulevard, 525@Vine 4th floor
Box 573152
Winston-Salem, NC 27157
Find A Doctor Ways to Give
Last Updated: 05-11-2015
Wake Forest Baptist Ranked among Nation’s ‘Best Hospitals’  25 Years in a Row by U.S. News & World ReportComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsNursing Magnet StatusJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.